Literature DB >> 33419065

Regulation of Postabsorptive and Postprandial Glucose Metabolism by Insulin-Dependent and Insulin-Independent Mechanisms: An Integrative Approach.

George D Dimitriadis1, Eirini Maratou2,3, Aikaterini Kountouri4, Mary Board5, Vaia Lambadiari4.   

Abstract

Glucose levels in blood must be constantly maintained within a tight physiological range to sustain anabolism. Insulin regulates glucose homeostasis via its effects on glucose production from the liver and kidneys and glucose disposal in peripheral tissues (mainly skeletal muscle). Blood levels of glucose are regulated simultaneously by insulin-mediated rates of glucose production from the liver (and kidneys) and removal from muscle; adipose tissue is a key partner in this scenario, providing nonesterified fatty acids (NEFA) as an alternative fuel for skeletal muscle and liver when blood glucose levels are depleted. During sleep at night, the gradual development of insulin resistance, due to growth hormone and cortisol surges, ensures that blood glucose levels will be maintained within normal levels by: (a) switching from glucose to NEFA oxidation in muscle; (b) modulating glucose production from the liver/kidneys. After meals, several mechanisms (sequence/composition of meals, gastric emptying/intestinal glucose absorption, gastrointestinal hormones, hyperglycemia mass action effects, insulin/glucagon secretion/action, de novo lipogenesis and glucose disposal) operate in concert for optimal regulation of postprandial glucose fluctuations. The contribution of the liver in postprandial glucose homeostasis is critical. The liver is preferentially used to dispose over 50% of the ingested glucose and restrict the acute increases of glucose and insulin in the bloodstream after meals, thus protecting the circulation and tissues from the adverse effects of marked hyperglycemia and hyperinsulinemia.

Entities:  

Keywords:  adipose tissue; fasting; incretins; insulin action secretion; liver; meal sequence; muscle; postabsorptive postprandial glucose metabolism

Mesh:

Substances:

Year:  2021        PMID: 33419065      PMCID: PMC7825450          DOI: 10.3390/nu13010159

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  299 in total

1.  Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas.

Authors:  R S Heller; T J Kieffer; J F Habener
Journal:  Diabetes       Date:  1997-05       Impact factor: 9.461

2.  The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm.

Authors:  R ANDRES; G CADER; K L ZIERLER
Journal:  J Clin Invest       Date:  1956-06       Impact factor: 14.808

Review 3.  Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.

Authors:  Antonio Ceriello; Enrico Motz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-02-19       Impact factor: 8.311

4.  Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus.

Authors:  J Wahren; L Hagenfeldt; P Felig
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

Review 5.  Substrate cycling between de novo lipogenesis and lipid oxidation: a thermogenic mechanism against skeletal muscle lipotoxicity and glucolipotoxicity.

Authors:  A G Dulloo; M Gubler; J P Montani; J Seydoux; G Solinas
Journal:  Int J Obes Relat Metab Disord       Date:  2004-12

6.  Ghrelin stimulates gastric emptying and hunger in normal-weight humans.

Authors:  F Levin; T Edholm; P T Schmidt; P Grybäck; H Jacobsson; M Degerblad; C Höybye; J J Holst; J F Rehfeld; P M Hellström; E Näslund
Journal:  J Clin Endocrinol Metab       Date:  2006-06-13       Impact factor: 5.958

7.  Ghrelin enhances appetite and increases food intake in humans.

Authors:  A M Wren; L J Seal; M A Cohen; A E Brynes; G S Frost; K G Murphy; W S Dhillo; M A Ghatei; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

8.  Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitro.

Authors:  G Dimitriadis; M Parry-Billings; S Bevan; D Dunger; T Piva; U Krause; G Wegener; E A Newsholme
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

9.  Pathways of hepatic glycogen formation in humans following ingestion of a glucose load in the fed state.

Authors:  I Magnusson; V Chandramouli; W C Schumann; K Kumaran; J Wahren; B R Landau
Journal:  Metabolism       Date:  1989-06       Impact factor: 8.694

10.  Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man.

Authors:  C A Verdonk; R A Rizza; J E Gerich
Journal:  Diabetes       Date:  1981-06       Impact factor: 9.461

View more
  12 in total

Review 1.  Effects of Diet, Lifestyle, Chrononutrition and Alternative Dietary Interventions on Postprandial Glycemia and Insulin Resistance.

Authors:  Emilia Papakonstantinou; Christina Oikonomou; George Nychas; George D Dimitriadis
Journal:  Nutrients       Date:  2022-02-16       Impact factor: 5.717

2.  Plasma Metabolic Signatures of Healthy Overweight Subjects Challenged With an Oral Glucose Tolerance Test.

Authors:  Jarlei Fiamoncini; Carlos M Donado-Pestana; Graziela Biude Silva Duarte; Milena Rundle; Elizabeth Louise Thomas; Yoana Kiselova-Kaneva; Thomas E Gundersen; Diana Bunzel; Jean-Pierre Trezzi; Sabine E Kulling; Karsten Hiller; Denise Sonntag; Diana Ivanova; Lorraine Brennan; Suzan Wopereis; Ben van Ommen; Gary Frost; Jimmy Bell; Christian A Drevon; Hannelore Daniel
Journal:  Front Nutr       Date:  2022-06-14

Review 3.  Approaches to Decrease Hyperglycemia by Targeting Impaired Hepatic Glucose Homeostasis Using Medicinal Plants.

Authors:  Gerardo Mata-Torres; Adolfo Andrade-Cetto; Fernanda Espinoza-Hernández
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

4.  Oral Administration of Bacillus toyonensis Strain SAU-20 Improves Insulin Resistance and Ameliorates Hepatic Steatosis in Type 2 Diabetic Mice.

Authors:  Zhihua Ren; Samuel Kumi Okyere; Lei Xie; Juan Wen; Jiayi Wang; Zhengli Chen; Xueqin Ni; Junliang Deng; Yanchun Hu
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

Review 5.  Current State and Principles of Basal Insulin Therapy in Type 2 Diabetes.

Authors:  Hernando Vargas-Uricoechea
Journal:  J Clin Med Res       Date:  2022-01-29

6.  Systemic Lactate Acts as a Metabolic Buffer in Humans and Prevents Nutrient Overflow in the Postprandial Phase.

Authors:  Lisa Schlicker; Gang Zhao; Christian-Alexander Dudek; Hanny M Boers; Michael Meyer-Hermann; Doris M Jacobs; Karsten Hiller
Journal:  Front Nutr       Date:  2022-03-10

Review 7.  Insulin Resistance Is Cheerfully Hitched with Hypertension.

Authors:  Susmita Sinha; Mainul Haque
Journal:  Life (Basel)       Date:  2022-04-10

8.  Chronic Central Leptin Infusion Promotes an Anti-Inflammatory Cytokine Profile Related to the Activation of Insulin Signaling in the Gastrocnemius of Male Rats.

Authors:  Vicente Barrios; Santiago Guerra-Cantera; Álvaro Martín-Rivada; Sandra Canelles; Ana Campillo-Calatayud; Eduardo Arilla-Ferreiro; Laura M Frago; Julie A Chowen; Jesús Argente
Journal:  Biomedicines       Date:  2022-06-21

Review 9.  Akt: A Potential Drug Target for Metabolic Syndrome.

Authors:  Runyu Miao; Xinyi Fang; Jiahua Wei; Haoran Wu; Xinmiao Wang; Jiaxing Tian
Journal:  Front Physiol       Date:  2022-03-07       Impact factor: 4.566

10.  The WWOX/HIF1A Axis Downregulation Alters Glucose Metabolism and Predispose to Metabolic Disorders.

Authors:  Izabela Baryła; Ewa Styczeń-Binkowska; Elżbieta Płuciennik; Katarzyna Kośla; Andrzej K Bednarek
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.